Protein Consistent Diet for Parkinson Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Alabama at Birmingham, Birmingham, AL
Parkinson Disease
Protein Consistent Diet - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this pilot study is to generate preliminary data on the impact of the dietary protein pattern on markers of skeletal muscle health and drug efficacy in Parkinson disease.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Parkinson Disease

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: Baseline to 5 weeks

Baseline to 5 weeks
Change in markers of skeletal muscle metabolism GDF15 and FGF21
Change in motor symptoms
Change in muscle strength
Change in physical activity
Change in sleep efficiency
Change in total Parkinson symptoms

Trial Safety

Safety Progress

1 of 3

Other trials for Parkinson Disease

Trial Design

2 Treatment Groups

Protein Consistent Diet
1 of 2
Protein Redistribution Diet
1 of 2
Active Control

20 Total Participants · 2 Treatment Groups

Primary Treatment: Protein Consistent Diet · No Placebo Group · N/A

Protein Consistent Diet
Behavioral
ActiveComparator Group · 1 Intervention: Protein Consistent Diet · Intervention Types: Behavioral
Protein Redistribution Diet
Behavioral
ActiveComparator Group · 1 Intervention: Protein Redistribution Diet · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 5 weeks

Trial Background

Christine Ferguson, RD, LD, MD PhD
Principal Investigator
University of Alabama at Birmingham
Closest Location: University of Alabama at Birmingham · Birmingham, AL
Photo of university of alabama at birmingham  1Photo of university of alabama at birmingham  2Photo of university of alabama at birmingham  3
1991First Recorded Clinical Trial
34 TrialsResearching Parkinson Disease
1066 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have idiopathic Parkinson's disease for 5 or more years.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.